Pasithea Therapeutics receives FDA rare pediatric disease designation for PAS-004

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. SPCX
8. HD
9. BJ
10. BABA

Go back to Pasithea Therapeutics receives FDA rare pediatric disease designation for PAS-004
(NASDAQ: KTTA) Delayed: 0.54 +0.07 (14.89%)
Previous Close $0.47    52 Week High $ 
Open $0.49    52 Week Low $ 
Day High $0.54    P/E N/A 
Day Low $0.48    EPS $ 
Volume 302,674       

(NASDAQ: KTTAW) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $ 
Open $0.01    52 Week Low $ 
Day High $0.01    P/E N/A 
Day Low $0.01    EPS $ 
Volume 46